O patrimônio e os bens culturais de Goiânia : uma outra perspectiva : uma análise a partir dos frequentadores do setor central

Trabalho de Conclusão de Curso (especialização)—Universidade de Brasília, Instituto de Artes, Programa de Pós-Graduação em Arte, 2018. Curso de Especialização em Educação e Patrimônio Cultural e Artístico a distância. Polo Goiás-GO.A presente pesquisa apresenta a perspectiva dos cidadãos no que se refere ao patrimônio cultural em Goiânia, com recorte na área do Setor Central, onde as pessoas abordadas estão mais próximas à maioria dos bens tombados. É realizado o resgate do conceito de patrimônio cultural e se expõe a sua evolução até a hodiernidade do entendimento desse conceito e sua abrangência. É feito, também, um diálogo com a história de Goiânia desde sua construção, relacionando ao urbanismo e à formação dos estilos arquitetônicos da capital. São apresentados, ainda, os instrumentos legais que contemplam o patrimônio do município, como atuam, e a atual situação de degradação da área histórica. Em termos metodológicos para captar as percepções foi utilizado questionário semiestruturado. Os resultados sinalizam no sentido que a maioria das pessoas tem noção do que significa patrimônio cultural, porém não conhece bem a história de Goiânia, tão pouco o estilo Art Déco que representa a cidade. Sinaliza-se que, embora essas pessoas não tenham muito conhecimento da história, acreditam que o bairro possui potencial para receber incentivos e se tornar atrativo para investimentos e turismo, que poderão ser alcançados com a sua recuperação. Após as informações apresentadas durante a aplicação do questionário, as pessoas foram estimuladas a divulgá-las e a observar a história a sua volta, o que mostra que o objetivo desta investigação foi alcançado e, concomitantemente, novas ideias para ações em educação patrimonial surgiram a partir dessa observação.The research presents the perspective of the citizens with regard to the cultural heritage in Goiânia, in the delimitation of the Central neighborhood, where the people approached are closer to most of the registered cultural heritage. The concept of cultural heritage is redeemed and its evolution is exposed until the modernity of the understanding which is more embracing. There is also a dialogue with the history of Goiania since its construction, relating to urbanism and the formation of the architectural styles of the capital. Also presented are the legal instruments that contemplate the heritage of the municipality, how they act, and the current situation of degradation of the historical area. In methodological terms to capture perceptions, a semi-structured questionnaire was used. The results indicate that most people are aware of what cultural heritage means, but they do not know the history of Goiânia well, so little does the Art Déco style that represents the city. It is noteworthy that although these people do not have much knowledge of the history, they believe that the neighborhood has the potential to receive incentives and become attractive for investment and tourism, which can be achieved with its recovery. After the information presented during the application of the questionnaire, people were encouraged to divulge them and to observe the history around them, which shows that the objective of this investigation was reached and, at the same time, new ideas for actions in heritage education came about from this observation

Avaliação da produtividade de mandioca em função de diferentes doses de fósforo / Evaluation of cassava productivity due to different doses of phosphorus

A mandioca (Manihot esculenta Crantz), é uma das mais promissoras culturas na agricultura familiar, contribuindo no desenvolvimento social e econômico do Brasil. Tradicionalmente a cultura é conduzida com baixo investimento financeiro, por vezes, não havendo aplicação de corretivos e fertilizantes em doses adequadas. O objetivo deste trabalho foi avaliar o efeito de diferentes doses de adubação fosfatada na produtividade de duas variedades de mandioca. O experimento foi realizado no município de Barreiras-Ba, empregando o delineamento experimental em blocos casualizados, com arranjo fatorial de 2x5, sendo duas cultivares de mandioca (Rio verde e BRS 396) em função de cinco doses de fósforo (0, 15, 30, 45 e 60 P2O5 kg/ha) com quatro repetições. A colheita foi realizada no dia vinte de julho de 2019, 10 meses após o plantio. Não foi observada diferença significativa entre as dosagens testadas em nenhuma das variáveis analisadas, já entre as cultivares, foi observada diferença significativa, onde a cultivar Rio Verde se mostrou mais produtiva que a cultivar BRS 396, com relação ao diâmetro, o comprimento, e produtividade de raízes, com exceção do número de raízes que foi igual para as duas cultivares. Foi observado que a média da produtividade da cultivar Rio Verde teve um incremento de 77% em relação a média da outra cultivar testada

AVALIAÇÃO IN VITRO DO POTENCIAL ANTIOXIDANTE DOS EXTRATOS ETANÓLICOS DAS CASCAS DE Spondias dulcis Forst F. E Spondias purpurea L.

Plantas com potencial terapêutico vêm sendo profundamente estudadas nos últimos anos, por serem de fácil acesso e apresentarem um baixo custo. Entre as plantas utilizadas pelo homem como fonte alimentícia e medicamentosa estão aquelas pertencentes ao gênero Spondias, e as espécies Spondias dulcis Forst. F. e Spondias purpurea L. produzem frutos comestíveis que são utilizados como medicamentos para diversas enfermidades. Embora essas plantas tenham diversas aplicações, nenhum estudo relacionando as propriedades antioxidantes da casca das mesmas está disponível atualmente. Dessa forma, o objetivo do presente trabalho foi avaliar a capacidade antioxidante dos extratos etanólicos das cascas da S. dulcis e S. purpurea, através da análise de seus efeitos de sequestro de espécies reativas em meio in vitro sem células. A avaliação foi feita através da geração das espécies reativas hidroxila (HO•), peróxido de hidrogênio (H2O2) e óxido nítrico (NO•) em meio in vitro e avaliação da porcentagem de sequestro dessas espécies pelo extrato, e através da medida da capacidade antioxidante total, pelo teste do fosfomolibdênio. A porcentagem de sequestro de espécies reativas e a capacidade antioxidante total foram comparadas com o ácido ascórbico (Vitamina C), um antioxidante muito bem conhecido. Também foram realizadas dosagens dos componentes fenólicos e flavonoides totais. Os extratos apresentaram alta capacidade de sequestro dos radicais HO• e NO•, e da espécies reativa H2O2, além de alta capacidade antioxidante total. Os extratos também apresentaram uma alta concentração de ácidos fenólicos em sua composição que explicam a alta capacidade antioxidante dos mesmos. Mais estudos estão sendo realizados para validar os efeitos terapêuticos destes extratos

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants.

BACKGROUND: Hypertension can be detected at the primary health-care level and low-cost treatments can effectively control hypertension. We aimed to measure the prevalence of hypertension and progress in its detection, treatment, and control from 1990 to 2019 for 200 countries and territories. METHODS: We used data from 1990 to 2019 on people aged 30-79 years from population-representative studies with measurement of blood pressure and data on blood pressure treatment. We defined hypertension as having systolic blood pressure 140 mm Hg or greater, diastolic blood pressure 90 mm Hg or greater, or taking medication for hypertension. We applied a Bayesian hierarchical model to estimate the prevalence of hypertension and the proportion of people with hypertension who had a previous diagnosis (detection), who were taking medication for hypertension (treatment), and whose hypertension was controlled to below 140/90 mm Hg (control). The model allowed for trends over time to be non-linear and to vary by age. FINDINGS: The number of people aged 30-79 years with hypertension doubled from 1990 to 2019, from 331 (95% credible interval 306-359) million women and 317 (292-344) million men in 1990 to 626 (584-668) million women and 652 (604-698) million men in 2019, despite stable global age-standardised prevalence. In 2019, age-standardised hypertension prevalence was lowest in Canada and Peru for both men and women; in Taiwan, South Korea, Japan, and some countries in western Europe including Switzerland, Spain, and the UK for women; and in several low-income and middle-income countries such as Eritrea, Bangladesh, Ethiopia, and Solomon Islands for men. Hypertension prevalence surpassed 50% for women in two countries and men in nine countries, in central and eastern Europe, central Asia, Oceania, and Latin America. Globally, 59% (55-62) of women and 49% (46-52) of men with hypertension reported a previous diagnosis of hypertension in 2019, and 47% (43-51) of women and 38% (35-41) of men were treated. Control rates among people with hypertension in 2019 were 23% (20-27) for women and 18% (16-21) for men. In 2019, treatment and control rates were highest in South Korea, Canada, and Iceland (treatment >70%; control >50%), followed by the USA, Costa Rica, Germany, Portugal, and Taiwan. Treatment rates were less than 25% for women and less than 20% for men in Nepal, Indonesia, and some countries in sub-Saharan Africa and Oceania. Control rates were below 10% for women and men in these countries and for men in some countries in north Africa, central and south Asia, and eastern Europe. Treatment and control rates have improved in most countries since 1990, but we found little change in most countries in sub-Saharan Africa and Oceania. Improvements were largest in high-income countries, central Europe, and some upper-middle-income and recently high-income countries including Costa Rica, Taiwan, Kazakhstan, South Africa, Brazil, Chile, Turkey, and Iran. INTERPRETATION: Improvements in the detection, treatment, and control of hypertension have varied substantially across countries, with some middle-income countries now outperforming most high-income nations. The dual approach of reducing hypertension prevalence through primary prevention and enhancing its treatment and control is achievable not only in high-income countries but also in low-income and middle-income settings. FUNDING: WHO

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

Background Hypertension can be detected at the primary health-care level and low-cost treatments can effectively control hypertension. We aimed to measure the prevalence of hypertension and progress in its detection, treatment, and control from 1990 to 2019 for 200 countries and territories. Methods We used data from 1990 to 2019 on people aged 30-79 years from population-representative studies with measurement of blood pressure and data on blood pressure treatment. We defined hypertension as having systolic blood pressure 140 mm Hg or greater, diastolic blood pressure 90 mm Hg or greater, or taking medication for hypertension. We applied a Bayesian hierarchical model to estimate the prevalence of hypertension and the proportion of people with hypertension who had a previous diagnosis (detection), who were taking medication for hypertension (treatment), and whose hypertension was controlled to below 140/90 mm Hg (control). The model allowed for trends over time to be non-linear and to vary by age. Findings The number of people aged 30-79 years with hypertension doubled from 1990 to 2019, from 331 (95% credible interval 306-359) million women and 317 (292-344) million men in 1990 to 626 (584-668) million women and 652 (604-698) million men in 2019, despite stable global age-standardised prevalence. In 2019, age-standardised hypertension prevalence was lowest in Canada and Peru for both men and women; in Taiwan, South Korea, Japan, and some countries in western Europe including Switzerland, Spain, and the UK for women; and in several low-income and middle-income countries such as Eritrea, Bangladesh, Ethiopia, and Solomon Islands for men. Hypertension prevalence surpassed 50% for women in two countries and men in nine countries, in central and eastern Europe, central Asia, Oceania, and Latin America. Globally, 59% (55-62) of women and 49% (46-52) of men with hypertension reported a previous diagnosis of hypertension in 2019, and 47% (43-51) of women and 38% (35-41) of men were treated. Control rates among people with hypertension in 2019 were 23% (20-27) for women and 18% (16-21) for men. In 2019, treatment and control rates were highest in South Korea, Canada, and Iceland (treatment >70%; control >50%), followed by the USA, Costa Rica, Germany, Portugal, and Taiwan. Treatment rates were less than 25% for women and less than 20% for men in Nepal, Indonesia, and some countries in sub-Saharan Africa and Oceania. Control rates were below 10% for women and men in these countries and for men in some countries in north Africa, central and south Asia, and eastern Europe. Treatment and control rates have improved in most countries since 1990, but we found little change in most countries in sub-Saharan Africa and Oceania. Improvements were largest in high-income countries, central Europe, and some upper-middle-income and recently high-income countries including Costa Rica, Taiwan, Kazakhstan, South Africa, Brazil, Chile, Turkey, and Iran. Interpretation Improvements in the detection, treatment, and control of hypertension have varied substantially across countries, with some middle-income countries now outperforming most high-income nations. The dual approach of reducing hypertension prevalence through primary prevention and enhancing its treatment and control is achievable not only in high-income countries but also in low-income and middle-income settings. Copyright (C) 2021 World Health Organization; licensee Elsevier

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

Background Hypertension can be detected at the primary health-care level and low-cost treatments can effectively control hypertension. We aimed to measure the prevalence of hypertension and progress in its detection, treatment, and control from 1990 to 2019 for 200 countries and territories. Methods We used data from 1990 to 2019 on people aged 30–79 years from population-representative studies with measurement of blood pressure and data on blood pressure treatment. We defined hypertension as having systolic blood pressure 140 mm Hg or greater, diastolic blood pressure 90 mm Hg or greater, or taking medication for hypertension. We applied a Bayesian hierarchical model to estimate the prevalence of hypertension and the proportion of people with hypertension who had a previous diagnosis (detection), who were taking medication for hypertension (treatment), and whose hypertension was controlled to below 140/90 mm Hg (control). The model allowed for trends over time to be non-linear and to vary by age. Findings The number of people aged 30–79 years with hypertension doubled from 1990 to 2019, from 331 (95% credible interval 306–359) million women and 317 (292–344) million men in 1990 to 626 (584–668) million women and 652 (604–698) million men in 2019, despite stable global age-standardised prevalence. In 2019, age-standardised hypertension prevalence was lowest in Canada and Peru for both men and women; in Taiwan, South Korea, Japan, and some countries in western Europe including Switzerland, Spain, and the UK for women; and in several low-income and middle-income countries such as Eritrea, Bangladesh, Ethiopia, and Solomon Islands for men. Hypertension prevalence surpassed 50% for women in two countries and men in nine countries, in central and eastern Europe, central Asia, Oceania, and Latin America. Globally, 59% (55–62) of women and 49% (46–52) of men with hypertension reported a previous diagnosis of hypertension in 2019, and 47% (43–51) of women and 38% (35–41) of men were treated. Control rates among people with hypertension in 2019 were 23% (20–27) for women and 18% (16–21) for men. In 2019, treatment and control rates were highest in South Korea, Canada, and Iceland (treatment >70%; control >50%), followed by the USA, Costa Rica, Germany, Portugal, and Taiwan. Treatment rates were less than 25% for women and less than 20% for men in Nepal, Indonesia, and some countries in sub-Saharan Africa and Oceania. Control rates were below 10% for women and men in these countries and for men in some countries in north Africa, central and south Asia, and eastern Europe. Treatment and control rates have improved in most countries since 1990, but we found little change in most countries in sub-Saharan Africa and Oceania. Improvements were largest in high-income countries, central Europe, and some upper-middle-income and recently high-income countries including Costa Rica, Taiwan, Kazakhstan, South Africa, Brazil, Chile, Turkey, and Iran. Interpretation Improvements in the detection, treatment, and control of hypertension have varied substantially across countries, with some middle-income countries now outperforming most high-income nations. The dual approach of reducing hypertension prevalence through primary prevention and enhancing its treatment and control is achievable not only in high-income countries but also in low-income and middle-income settings

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

Background Hypertension can be detected at the primary health-care level and low-cost treatments can effectively control hypertension. We aimed to measure the prevalence of hypertension and progress in its detection, treatment, and control from 1990 to 2019 for 200 countries and territories. Methods We used data from 1990 to 2019 on people aged 30–79 years from population-representative studies with measurement of blood pressure and data on blood pressure treatment. We defined hypertension as having systolic blood pressure 140 mm Hg or greater, diastolic blood pressure 90 mm Hg or greater, or taking medication for hypertension. We applied a Bayesian hierarchical model to estimate the prevalence of hypertension and the proportion of people with hypertension who had a previous diagnosis (detection), who were taking medication for hypertension (treatment), and whose hypertension was controlled to below 140/90 mm Hg (control). The model allowed for trends over time to be non-linear and to vary by age. Findings The number of people aged 30–79 years with hypertension doubled from 1990 to 2019, from 331 (95% credible interval 306–359) million women and 317 (292–344) million men in 1990 to 626 (584–668) million women and 652 (604–698) million men in 2019, despite stable global age-standardised prevalence. In 2019, age-standardised hypertension prevalence was lowest in Canada and Peru for both men and women; in Taiwan, South Korea, Japan, and some countries in western Europe including Switzerland, Spain, and the UK for women; and in several low-income and middle-income countries such as Eritrea, Bangladesh, Ethiopia, and Solomon Islands for men. Hypertension prevalence surpassed 50% for women in two countries and men in nine countries, in central and eastern Europe, central Asia, Oceania, and Latin America. Globally, 59% (55–62) of women and 49% (46–52) of men with hypertension reported a previous diagnosis of hypertension in 2019, and 47% (43–51) of women and 38% (35–41) of men were treated. Control rates among people with hypertension in 2019 were 23% (20–27) for women and 18% (16–21) for men. In 2019, treatment and control rates were highest in South Korea, Canada, and Iceland (treatment >70%; control >50%), followed by the USA, Costa Rica, Germany, Portugal, and Taiwan. Treatment rates were less than 25% for women and less than 20% for men in Nepal, Indonesia, and some countries in sub-Saharan Africa and Oceania. Control rates were below 10% for women and men in these countries and for men in some countries in north Africa, central and south Asia, and eastern Europe. Treatment and control rates have improved in most countries since 1990, but we found little change in most countries in sub-Saharan Africa and Oceania. Improvements were largest in high-income countries, central Europe, and some upper-middle-income and recently high-income countries including Costa Rica, Taiwan, Kazakhstan, South Africa, Brazil, Chile, Turkey, and Iran. Interpretation Improvements in the detection, treatment, and control of hypertension have varied substantially across countries, with some middle-income countries now outperforming most high-income nations. The dual approach of reducing hypertension prevalence through primary prevention and enhancing its treatment and control is achievable not only in high-income countries but also in low-income and middle-income settings

RESIDENCIAL GOIÂNIA VIVA: UMA PROPOSTA DE REINSERÇÃO SOCIOESPACIAL (1990).

Made available in DSpace on 2016-08-10T10:50:09Z (GMT). No. of bitstreams: 1 Leandra de Brito Rodrigues.pdf: 6372687 bytes, checksum: f554020f54091186cdcc5797bb1d9404 (MD5) Previous issue date: 2014-05-07A questão habitacional em Goiânia é um dos principais problemas relacionados à urbanização. Uma cidade marcada por ocupações irregulares, aonde as políticas habitacionais vêm tentando sanar esse problema, produzindo inúmeras habitações, com a finalidade de relocar posseiros e oferecer oportunidades à população de baixa renda. Essa pesquisa visa apresentar uma proposta diferenciada que aconteceu no Residencial Goiânia Viva, na década de 1990, através de alguns programas habitacionais que utilizaram materiais alternativos e buscaram a inserção da população no trabalho. Foi um período de tentativas que se contrapôs ao que têm sido visto nos dias atuais - um trabalho repetitivo e que demonstra pouca evolução. Ênfase especial é dada ao PROTECH, programa que teve como objetivo a implantação de Vilas Tecnológicas nas principais cidades brasileiras, um modelo que deveria direcionar os próximos programas habitacionais, mas que não foi levado adiante em Goiânia. As experiências de outras cidades também revelam dificuldades dos mais diversos tipos nesse trabalho de inovação, onde a identificação das mesmas se torna necessária para aprimorar propostas futuras

Estudo da paisagem de Goiânia-GO: os bens culturais sob a perspectiva dos cidadãos

Tendo em vista o acervo arquitetônico que marca a paisagem de Goiânia, esta pesquisa expõe a perspectiva dos cidadãos referente ao patrimônio cultural dessa cidade. O recorte da investigação é a área do Setor Central, onde as pessoas abordadas estão mais próximas à maioria dos bens tombados. Resgata-se o conceito de patrimônio cultural e se discute a sua abrangência, considerando os estilos arquitetônicos de Goiânia. Os resultados sinalizam no sentido que a maioria das pessoas tem noção do que significa patrimônio cultural, porém não conhecem bem a história de Goiânia, nem o estilo Art Déco que representa a cidade